![glp-1 receptor agonists list PDF] Glucagon-Like Peptide-1 (GLP-1) Drug Class Review Mapping the effectiveness and risks](https://figures.semanticscholar.org/d4633364bbf2cc67e74fd3a60dd5180b7e50f90a/5-Table1-1.png)
glp-1 receptor agonists list PDF] Glucagon-Like Peptide-1 (GLP-1) Drug Class Review Mapping the effectiveness and risks
Description
Among all medicines worldwide, treatments for obesity and diabetes featuring GLP-1 agonists have surged to the top of the best-seller lists in the first half of 2025
![glp-1 receptor agonists list PDF] Glucagon-Like Peptide-1 (GLP-1) Drug Class Review Mapping the effectiveness and risks](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-024-03412-w/MediaObjects/41591_2024_3412_Fig6_HTML.png)
Clinical trials show that people without diabetes can lose 617% of their body weight on GLP-1 drugs, while those with diabetes typically lose 46%
![glp-1 receptor agonists list PDF] Glucagon-Like Peptide-1 (GLP-1) Drug Class Review Mapping the effectiveness and risks](https://media.licdn.com/dms/image/v2/D4E12AQFfuNPuHQsNlA/article-inline_image-shrink_1500_2232/article-inline_image-shrink_1500_2232/0/1721306352440?e=2147483647&v=beta&t=BCIyqrmgEko78XdY4ydavOz2LG0GFVngoaeXqbMvbV0)
Additionally, tirzepatide improved quality-of-life scores and reduced the incidence of sleep-related cardiovascular events
![glp-1 receptor agonists list PDF] Glucagon-Like Peptide-1 (GLP-1) Drug Class Review Mapping the effectiveness and risks](https://www.ijbs.com/ms/getimage.php?name=ijbsv17p2050g002.jpg)
Injectable GLP-1 RAs like liraglutide, semaglutide, and dulaglutide have been shown to significantly lower HbA1c and body weight in patients with T2DM
![glp-1 receptor agonists list PDF] Glucagon-Like Peptide-1 (GLP-1) Drug Class Review Mapping the effectiveness and risks](https://pandameds.com/wp-content/uploads/2025/12/GLP-1-Receptor-Agonists.webp)
